Cover Image
Market Research Report

US Product Portfolio for Gastrointestinal Devices 2017 - MedFolio

Published by iData Research Inc. Product code 378998
Published Content info 161 Pages
Delivery time: 1-2 business days
Price
Back to Top
US Product Portfolio for Gastrointestinal Devices 2017 - MedFolio
Published: October 1, 2016 Content info: 161 Pages
Description

The U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret's Esophagus. The largest segment in the total GI endoscopic device market was the GI flexible endoscope segment. This segment represented approximately 24.5% of the total market in 2016. The relatively large size of this segment is due to a combination of relatively high average selling price (ASP) coupled with relatively short life-span of five years, resulting in constant renewal of the equipment. One of the main drivers in this market is the growth in the procedure numbers, such as colonoscopy and therapeutic ERCP. Colonoscopy has become a gold-standard in the colorectal cancer screening program, with more than 18 million procedures performed annually. A lot of devices discussed in this report are used in conjunction with the each other, thus having a multiplication effect on the size of the market with each extra procedure performed.

The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret's Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.

Table of Contents
Product Code: iDATA_USGI17_MF

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

PROCEDURE CODES INVESTIGATED

MARKETS INCLUDED

1.1 KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1 RESEARCH SCOPE
  • 1.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1 BASIC ANATOMY
  • 2.2 GASTROINTESTINAL DISEASE: TREATMENT AND DIAGNOSTICS
    • 2.2.1 Gastro-Esophageal Reflux Disease (GERD)
    • 2.2.2 Barrett's Esophagus
    • 2.2.3 Digestive Cancer
    • 2.2.4 Gastrointestinal bleeding
    • 2.2.5 Bile Duct Disorders
    • 2.2.6 Crohn's disease
    • 2.2.7 Ulcer
    • 2.2.8 Ogilvie Syndrome or Intestinal Pseudo-Obstruction
  • 2.3 PATIENT DEMOGRAPHICS
    • 2.3.11 Patient Demographics
      • 2.3.11.1 All Digestive Diseases
      • 2.3.11.2 Abdominal Wall Hernia
      • 2.3.11.3 Chronic Constipation
      • 2.3.11.4 Diverticular Disease
      • 2.3.11.5 Prescriptions
      • 2.3.11.6 Gastroesophageal Reflux Disease
      • 2.3.11.7 Gastrointestinal Infections
      • 2.3.11.8 Hemorrhoids
      • 2.3.11.9 Inflammatory Bowel Disease
      • 2.3.11.10 Liver Disease
      • 2.3.11.11 Pancreatitis
      • 2.3.11.12 Peptic Ulcer Diseases
    • 2.3.12 Digestive Cancer

PRODUCT ASSESSMENT

  • 3.1 PRODUCT PORTFOLIOS
    • 3.1.1 Gastrointestinal Endoscopes
      • 3.1.1.1 Introduction 49
      • 3.1.1.1.1 Product Matrix for GI Endoscope Market
    • 3.1.2 Capsule Endoscopy
      • 3.1.2.1 Introduction
        • 3.1.2.1.1 Product Matrix for Capsule Endoscope Market
    • 3.1.3 Virtual Colonoscopy
      • 3.1.3.1 Introduction
        • 3.1.3.1.1 Product Matrix for Virtual Colonoscopy Market
    • 3.1.4 Stenting and Dilation devices
      • 3.1.4.1 Introduction
        • 3.1.4.1.1 Product Matrix for Stenting and Dilation Device Market
    • 3.1.5 Endoscopic Retrograde Cholangiopancreatography (ERCP) devices
      • 3.1.5.1 Introduction
        • 3.1.5.1.1 Product Matrix for ERCP Device Market
    • 3.1.6 Biopsy Forceps, Polypectomy Snares, Fine Aspiration Needles
      • 3.1.6.1 Introduction
        • 3.1.6.1.1 Product Matrix for Biopsy Forceps, Polypectomy Snares and FNA
    • 3.1.7 Foreign Body Retrieval and Specimen Removal devices
      • 3.1.7.1 Introduction
        • 3.1.7.1.1 Product matrix for Specimen Retrieval and Foreign Body Removal Devices
    • 3.1.8 Hemostasis Devices
      • 3.1.8.1 Introduction
        • 3.1.8.1.1 Product Matrix for Hemostasis Devices
    • 3.1.9 Enteral Feeding Devices
      • 3.1.9.1 Introduction
        • 3.1.9.1.1 Product Matrix for Enteral Feeding Devices
    • 3.1.10 Anti-Reflux Devices for Treatment of GERD
      • 3.1.10.1 Introduction
        • 3.1.10.1.1 Product Matrix for Anti-Reflux Device Market
    • 3.1.11 Barrett's Esophagus Ablation devices
      • 3.1.11.1 Introduction
        • 3.1.11.1.1 Product Matrix for Barret's Esophagus Ablation Device Market
  • 3.2 REGULATORY ISSUES AND RECALLS
    • 3.2.1 Gastrointestinal endoscopes
    • 3.2.2 Refurbishment endoscopes
    • 3.2.3 Stenting and Dilation device
    • 3.2.4 Biopsy Forceps, Polypectomy Snares, Fine Aspiration Needles
    • 3.2.5 Foreign Body Retrieval and Specimen Removal devices
    • 3.2.6 Endoscopic Retrograde Cholangiopancreatography (ERCP) devices
    • 3.2.7 Hemostasis devices
    • 3.2.8 Enteral Feeding Devices
    • 3.2.9 Anti-Reflux devices for treatment of GERD - and capsule
    • 3.2.10 Barrett's Esophagus Ablation devices
  • 3.3 CLINICAL TRIALS
    • 3.3.1 Gastrointestinal Endoscopes
    • 3.3.2 Capsule Endoscopy
    • 3.3.3 Virtual Colonoscopy
    • 3.3.4 Stenting and Dilation Device
    • 3.3.5 Endoscopic Retrograde Cholangiopancreatography (ERCP) devices
    • 3.3.6 Biopsy Forceps, Polypectomy Snares and Fine Aspirational Needle
    • 3.3.7 Foreign Body and Specimen Removal devices
    • 3.3.8 Hemostasis devices
    • 3.3.9 Enteral Feeding Devices
    • 3.3.10 Anti-Reflux (GERD) devices
    • 3.3.11 Barrett's Esophagus Ablation devices
  • 3.4 PRODUCT PIPELINES
    • 3.4.1 Boston Scientific
      • 3.4.1.1 AXIOS™ Stent and Electrocautery Enhanced Delivery System
      • 3.4.1.2 Acquire™ Endoscopic Ultrasound Fine Needle Biopsy (FNB) Device
      • 3.4.1.3 Safe Enteral Feeding Product
      • 3.4.1.4 Rotatable Snare
    • 3.4.2 Cook Inc.
      • 3.4.2.1 Lehman Manometry Catheter
    • 3.4.3 Olympus
      • 3.4.3.1 Olympus EZ Shot 3 Plus - a single-use aspiration needle
      • 3.4.3.2 Olympus ESG-200 Electrosurgical Generator
      • 3.4.3.3 Retooled GI Benchmarking Service
      • 3.4.3.4 Big Screen Surgery In 4K: VISERA 4K UHD System
      • 3.4.3.5 TJF-Q180V Duodenoscope
      • 3.4.3.6 From AR 2015 - new strategy plan for General Surgery Unit
    • 3.4.4 Medtronic / Covidien
      • 3.4.4.1 Safe Enteral Feeding Product line 2016
      • 3.4.4.2 Barrx 360 Express RFA balloon catheter for Barrett's Esophagus
    • 3.4.5 Avantis Medical Systems
      • 3.4.5.1 Third Eye Panoramic Colonoscopy Device
      • 3.4.6 Pentax Medical/ HOYA
    • 3.4.6.1 H OPTIVISTA-EPK-i7010 Video Processor for endoscopy
    • 3.4.7 Fujifilm
      • 3.4.7.1 Sonart SU-1 Endoscopic Ultrasonic Processors
      • 3.4.7.2 Double Balloon Endoscope (EN-580T)
    • 3.4.8 US Endoscopy
      • 3.4.8.1 Moray® micro forceps
    • 3.4.9 CONMED Corporation
      • 3.4.9.1 ABC D-Flex Probes
    • 3.4.10 EndoChoice
      • 3.4.10.1 FDA clearance for Orca™ Sterile, Single-Use Air/Water and Suction Valves
      • 3.4.10.2 Third generation Fuse® Full Spectrum Endoscopy® System
      • 3.4.10.3 RescueNet™ retrieval device
      • 3.4.10.4 Lumos™ Adaptive Matrix Imaging System
    • 3.4.11 Endogastric Solution
      • 3.4.11.1 Next-generation version of EsophyX® Device - EsophyX® Z
    • 3.4.12 Mederi Therapeutics
      • 3.4.12.1 Stretta RFT3 Technology
    • 3.4.13 C2 Therapeutics
      • 3.4.13.1 Coldplay III Trial Validating the C2 CryoBalloon™ Focal Ablation System for treating Barret's Esophagus
    • 3.4.14 Medigus
      • 3.4.14.1 Next generation MUSE™ System for the long-term treatment of GERD
    • 3.4.15 Merit Medical Systems, Inc.
      • 3.4.15.1 Corvocet Biopsy System
    • 3.4.16 Medivators, Inc.
      • 3.4.16.1 AmplifEYE™ endoscopic overtube
    • 3.4.17 Fujifilm Medical Systems USA, Inc.
      • 3.4.17.1 Fujifilm Diathermic Slitter (flushknife) and Fujifilm Diathermic Slitter (clutchcutter)
      • 3.4.17.2 New additions for Double Balloon Endoscopy (DBE) platform and the Advanced Endoscopic Platform including FlushKnife and ClutchCutter
    • 3.4.18 Cook Medical
      • 3.4.18.1 New study "A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device (ASPRO)"
    • 3.4.19 Vital Images, Inc.
      • 3.4.19.1 Vitrea CT Colon Analysis

ABBREVIATIONS

Back to Top